{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:25:24Z","timestamp":1777598724181,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2314070000086"],"award-info":[{"award-number":["2314070000086"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age. It is characterized by hyperandrogenism, ovulatory dysfunction, and the presence of polycystic ovarian morphology (PCOM) on ultrasound, often accompanied by metabolic disturbances such as insulin resistance and obesity. Current treatments, including oral contraceptives and anti-androgen medications, often yield limited efficacy and undesirable side effects. This study investigates the role of UGT2B15, an essential enzyme for androgen metabolism, in PCOS pathogenesis and its potential as a therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We used RNA sequencing to examine the effects of UGT2B15 knockdown in KGN cells. To modulate UGT2B15 expression, we employed siRNA and\n                      <jats:italic>(R)\/(S)<\/jats:italic>\n                      -NAF (naftopidil), a chemical inducer of UGT2B15 identified in our previous studies on a prostate hyperplasia model. The effects of siRNA and\n                      <jats:italic>(R)\/(S)<\/jats:italic>\n                      -NAF on dihydrotestosterone (DHT) levels, cell apoptosis, and the expression of apoptosis-related proteins in KGN cells were evaluated. In a PCOS mouse model, we assessed the effects of\n                      <jats:italic>(R)<\/jats:italic>\n                      -NAF and\n                      <jats:italic>(S)<\/jats:italic>\n                      -NAF on serum androgen levels, menstrual cycles, ovarian morphology, and UGT2Bs expression. Additionally, luciferase reporter and ChIP assays were utilized to study UGT2B15 regulation by NR1H4.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Elevated androgens were found to suppress UGT2B15 expression in ovarian granulosa cells, leading to DHT accumulation and apoptosis.\n                      <jats:italic>(R)<\/jats:italic>\n                      -NAF and\n                      <jats:italic>(S)<\/jats:italic>\n                      -NAF treatments reversed these effects, alleviating PCOS symptoms in mice such as hyperandrogenism, irregular menstrual cycles, and the presence of ovarian cysts. NR1H4 negatively regulated the transcription of UGT2B15 in KGN cells.\n                      <jats:italic>(R)<\/jats:italic>\n                      -NAF and\n                      <jats:italic>(S)<\/jats:italic>\n                      -NAF disrupted NR1H4 binding to the UGT2B15 promoter without affecting its protein levels, indicating direct interference with its regulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      UGT2B15 represents a promising target for novel PCOS therapies by modulating androgen metabolism and protecting ovarian granulosa cells from apoptosis.\n                      <jats:italic>(R)<\/jats:italic>\n                      -NAF and\n                      <jats:italic>(S)<\/jats:italic>\n                      -NAF regulate UGT2B15 by disrupting NR1H4's binding to its promoter, implying potential therapeutic compounds for PCOS treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-025-01598-2","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:41:07Z","timestamp":1737693667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiufen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zikai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiawen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021203","volume":"25","author":"S Matsuyama","year":"2024","unstructured":"Matsuyama S, Whiteside S, Li S-Y. Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy. Int J Mol Sci. 2024;25: 1203. https:\/\/doi.org\/10.3390\/ijms25021203.","journal-title":"Int J Mol Sci"},{"key":"1598_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/diagnostics13061113","volume":"13","author":"JP Christ","year":"2023","unstructured":"Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 2023;13:1113. https:\/\/doi.org\/10.3390\/diagnostics13061113.","journal-title":"Diagnostics (Basel)"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021;106:e1071\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgaa839.","journal-title":"J Clin Endocrinol Metab"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3803\/EnM.2021.958","volume":"36","author":"SH Oguz","year":"2021","unstructured":"Oguz SH, Yildiz BO. An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab. 2021;36:296\u2013311. https:\/\/doi.org\/10.3803\/EnM.2021.958.","journal-title":"Endocrinol Metab"},{"key":"1598_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/cen.14013","volume":"91","author":"H Teede","year":"2019","unstructured":"Teede H, Tassone EC, Piltonen T, et al. Effect of the combined oral contraceptive pill and\/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses. Clin Endocrinol (Oxf). 2019;91:479\u201389. https:\/\/doi.org\/10.1111\/cen.14013.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, Shorakae S, de Courten B, et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21:560\u201374. https:\/\/doi.org\/10.1093\/humupd\/dmv025.","journal-title":"Hum Reprod Update"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10:668\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.diabres.2013.12.054","volume":"104","author":"ML Tung","year":"2014","unstructured":"Tung ML, Tan LK. Long term use of metformin leading to vitamin B 12 deficiency. Diabetes Res Clin Pract. 2014;104:e75-76. https:\/\/doi.org\/10.1016\/j.diabres.2013.12.054.","journal-title":"Diabetes Res Clin Pract"},{"key":"1598_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"SK Ramu","year":"2022","unstructured":"Ramu SK, Praveen, Ankith, Yadav K. Study of Diversity of Metformin Related Gastrointestinal Side Effects. J Assoc Physicians India. 2022;70:11\u20132.","journal-title":"J Assoc Physicians India."},{"key":"1598_CR10","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1210\/jc.2005-2250","volume":"91","author":"A Gambineri","year":"2006","unstructured":"Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab. 2006;91:3970\u201380. https:\/\/doi.org\/10.1210\/jc.2005-2250.","journal-title":"J Clin Endocrinol Metab"},{"key":"1598_CR11","doi-asserted-by":"publisher","unstructured":"Kanbour SA, Dobs AS. Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies. Androgens Clin Res Ther. 2022.\u00a0https:\/\/doi.org\/10.1089\/andro.2021.0020.","DOI":"10.1089\/andro.2021.0020"},{"key":"1598_CR12","doi-asserted-by":"publisher","unstructured":"Yang R, Li Q, Zhou Z, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health \u2013 West Pac. 2022;25. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100494.","DOI":"10.1016\/j.lanwpc.2022.100494"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1262\/jrd.2011-012","volume":"58","author":"F Matsuda","year":"2012","unstructured":"Matsuda F, Inoue N, Manabe N, Ohkura S. Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J Reprod Dev. 2012;58:44\u201350. https:\/\/doi.org\/10.1262\/jrd.2011-012.","journal-title":"J Reprod Dev"},{"key":"1598_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaad017","volume":"29","author":"AC Lissaman","year":"2023","unstructured":"Lissaman AC, Girling JE, Cree LM, et al. Androgen signalling in the ovaries and endometrium. Mol Hum Reprod. 2023;29: gaad017. https:\/\/doi.org\/10.1093\/molehr\/gaad017.","journal-title":"Mol Hum Reprod"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/medsci7090089","volume":"7","author":"V Rodriguez Paris","year":"2019","unstructured":"Rodriguez Paris V, Bertoldo MJ. The Mechanism of Androgen Actions in PCOS Etiology. Med Sci (Basel). 2019;7:89. https:\/\/doi.org\/10.3390\/medsci7090089.","journal-title":"Med Sci (Basel)"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"W Ye","year":"2021","unstructured":"Ye W, Xie T, Song Y, Zhou L. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021;25:1825\u201337. https:\/\/doi.org\/10.1111\/jcmm.16205.","journal-title":"J Cell Mol Med"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M, et al. Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22:709\u201324. https:\/\/doi.org\/10.1093\/humupd\/dmw027.","journal-title":"Hum Reprod Update"},{"key":"1598_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1110\/ps.051905906","volume":"15","author":"K Pereira de J\u00e9sus-Tran","year":"2006","unstructured":"Pereira de J\u00e9sus-Tran K, C\u00f4t\u00e9 PL, Cantin L, et al. Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Sci. 2006;15:987\u201399. https:\/\/doi.org\/10.1110\/ps.051905906.","journal-title":"Protein Sci"},{"key":"1598_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1210\/jc.2014-2523","volume":"100","author":"J M\u00fcnzker","year":"2015","unstructured":"M\u00fcnzker J, Hofer D, Trummer C, et al. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100:653\u201360. https:\/\/doi.org\/10.1210\/jc.2014-2523.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"1598_CR20","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3-5. https:\/\/doi.org\/10.1016\/s0015-0282(02)02985-0.","journal-title":"Fertil Steril"},{"key":"1598_CR21","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1210\/endo.142.6.8040","volume":"142","author":"O Barbier","year":"2001","unstructured":"Barbier O, Girard C, Berger L, et al. The androgen-conjugating uridine diphosphoglucuronosyltransferase-2B enzymes are differentially expressed temporally and spatially in the monkey follicle throughout the menstrual cycle. Endocrinology. 2001;142:2499\u2013507. https:\/\/doi.org\/10.1210\/endo.142.6.8040.","journal-title":"Endocrinology"},{"key":"1598_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019444","volume":"99","author":"Y Luo","year":"2020","unstructured":"Luo Y, Nie Y, Tang L, et al. The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients. Medicine (Baltimore). 2020;99: e19444. https:\/\/doi.org\/10.1097\/MD.0000000000019444.","journal-title":"Medicine (Baltimore)"},{"key":"1598_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-59745-310-3_6","volume-title":"Insulin Resistance and Polycystic Ovarian Syndrome","author":"K \u00dcnl\u00fchizarci","year":"2007","unstructured":"\u00dcnl\u00fchizarci K, Kele\u015ftimur F. Anti-Androgens. In: Insulin Resistance and Polycystic Ovarian Syndrome. Humana Press; 2007. p. 69\u201378."},{"key":"1598_CR24","doi-asserted-by":"publisher","unstructured":"Alesi S, Forslund M, Melin J, et al. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. eClinicalMedicine. 2023;63. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102162.","DOI":"10.1016\/j.eclinm.2023.102162"},{"key":"1598_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1517\/14728222.2015.1075511","volume":"19","author":"M Luque-Ram\u00edrez","year":"2015","unstructured":"Luque-Ram\u00edrez M, Escobar-Morreale HF. Targets to treat androgen excess in polycystic ovary syndrome. Expert Opin Ther Targets. 2015;19:1545\u201360. https:\/\/doi.org\/10.1517\/14728222.2015.1075511.","journal-title":"Expert Opin Ther Targets"},{"key":"1598_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0960-0760(97)00183-0","volume":"65","author":"A B\u00e9langer","year":"1998","unstructured":"B\u00e9langer A, Hum DW, Beaulieu M, et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol. 1998;65:301\u201310. https:\/\/doi.org\/10.1016\/s0960-0760(97)00183-0.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tem.2003.10.005","volume":"14","author":"A B\u00e9langer","year":"2003","unstructured":"B\u00e9langer A, Pelletier G, Labrie F, et al. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab. 2003;14:473\u20139. https:\/\/doi.org\/10.1016\/j.tem.2003.10.005.","journal-title":"Trends Endocrinol Metab"},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1158\/0008-5472.CAN-13-1462","volume":"73","author":"L Grosse","year":"2013","unstructured":"Grosse L, P\u00e2quet S, Caron P, et al. Androgen Glucuronidation: An Unexpected Target for Androgen Deprivation Therapy, with Prognosis and Diagnostic Implications. Cancer Res. 2013;73:6963\u201371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1462.","journal-title":"Cancer Res"},{"key":"1598_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.phrs.2016.02.021","volume":"106","author":"X Qin","year":"2016","unstructured":"Qin X, Liu M, Wang X. New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs. Pharmacol Res. 2016;106:114\u201322. https:\/\/doi.org\/10.1016\/j.phrs.2016.02.021.","journal-title":"Pharmacol Res"},{"key":"1598_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2022.106117","volume":"221","author":"H Zhan","year":"2022","unstructured":"Zhan H, Zhang S, Li L, et al. Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia. J Steroid Biochem Mol Biol. 2022;221: 106117. https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106117.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1598_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115824","volume":"301","author":"R Zheng","year":"2023","unstructured":"Zheng R, Shen H, Li J, et al. Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2\/HO-1\/Cyp1b1 pathway: integrating network pharmacology and experimental validation in vivo. J Ethnopharmacol. 2023;301: 115824. https:\/\/doi.org\/10.1016\/j.jep.2022.115824.","journal-title":"J Ethnopharmacol"},{"key":"1598_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1070264","volume":"14","author":"Q Peng","year":"2023","unstructured":"Peng Q, Chen X, Liang X, et al. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis. Front Endocrinol. 2023;14: 1070264. https:\/\/doi.org\/10.3389\/fendo.2023.1070264.","journal-title":"Front Endocrinol"},{"key":"1598_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NGM, et al. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127:569\u201380. https:\/\/doi.org\/10.1530\/rep.1.00095.","journal-title":"Reproduction"},{"key":"1598_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121672","volume":"322","author":"G Sudhakaran","year":"2023","unstructured":"Sudhakaran G, Babu SR, Mahendra H, Arockiaraj J. Updated experimental cellular models to study polycystic ovarian syndrome. Life Sci. 2023;322: 121672. https:\/\/doi.org\/10.1016\/j.lfs.2023.121672.","journal-title":"Life Sci"},{"key":"1598_CR35","doi-asserted-by":"publisher","first-page":"109094","DOI":"10.1016\/j.abb.2021.109094","volume":"715","author":"R Ji","year":"2022","unstructured":"Ji R, Jia F, Chen X, et al. Salidroside alleviates oxidative stress and apoptosis via AMPK\/Nrf2 pathway in DHT-induced human granulosa cell line KGN. Arch Biochem Biophys. 2022;715:109094. https:\/\/doi.org\/10.1016\/j.abb.2021.109094.","journal-title":"Arch Biochem Biophys"},{"key":"1598_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/pros.20749","volume":"68","author":"B-Y Bao","year":"2008","unstructured":"Bao B-Y, Chuang B-F, Wang Q, et al. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate. 2008;68:839\u201348. https:\/\/doi.org\/10.1002\/pros.20749.","journal-title":"Prostate"},{"key":"1598_CR37","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1210\/en.2006-0229","volume":"147","author":"S Chouinard","year":"2006","unstructured":"Chouinard S, Pelletier G, B\u00e9langer A, Barbier O. Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology. 2006;147:5431\u201342.","journal-title":"Endocrinology"},{"key":"1598_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/BJ20071136","volume":"410","author":"J Kaeding","year":"2008","unstructured":"Kaeding J, Bouchaert E, B\u00e9langer J, et al. Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem J. 2008;410:245\u201353. https:\/\/doi.org\/10.1042\/BJ20071136.","journal-title":"Biochem J"},{"key":"1598_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","volume":"99","author":"R Meech","year":"2019","unstructured":"Meech R, Hu DG, McKinnon RA, et al. The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms. Physiol Rev. 2019;99:1153\u2013222. https:\/\/doi.org\/10.1152\/physrev.00058.2017.","journal-title":"Physiol Rev"},{"key":"1598_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci. 2019;236: 116940. https:\/\/doi.org\/10.1016\/j.lfs.2019.116940.","journal-title":"Life Sci"},{"key":"1598_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1756287212461681","volume":"5","author":"N Hara","year":"2013","unstructured":"Hara N, Mizusawa T, Obara K, Takahashi K. The role of naftopidil in the management of benign prostatic hyperplasia. Ther Adv Urol. 2013;5:111\u20139. https:\/\/doi.org\/10.1177\/1756287212461681.","journal-title":"Ther Adv Urol"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1124\/dmd.106.012070","volume":"35","author":"DB Buckley","year":"2007","unstructured":"Buckley DB, Klaassen CD. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos. 2007;35:121\u20137. https:\/\/doi.org\/10.1124\/dmd.106.012070.","journal-title":"Drug Metab Dispos"},{"key":"1598_CR43","unstructured":"Species differences in UDP-glucuronosyltransferase activities in mice and rats - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/18505787\/. Accessed 11 Jul 2024."},{"key":"1598_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/03602532.2014.973037","volume":"46","author":"DG Hu","year":"2014","unstructured":"Hu DG, Meech R, McKinnon RA, Mackenzie PI. Transcriptional regulation of human UDP-glucuronosyltransferase genes. Drug Metab Rev. 2014;46:421\u201358. https:\/\/doi.org\/10.3109\/03602532.2014.973037.","journal-title":"Drug Metab Rev"},{"key":"1598_CR45","unstructured":"The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/20070244\/. Accessed 11 Jul 2024."},{"key":"1598_CR46","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1158\/0008-5472.CAN-15-3372","volume":"76","author":"DG Hu","year":"2016","unstructured":"Hu DG, Selth LA, Tarulli GA, et al. Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17. Cancer Res. 2016;76:5881\u201393. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3372.","journal-title":"Cancer Res"},{"key":"1598_CR47","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1124\/dmd.110.035436","volume":"38","author":"DG Hu","year":"2010","unstructured":"Hu DG, Mackenzie PI. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells. Drug Metab Dispos. 2010;38:2105\u20139. https:\/\/doi.org\/10.1124\/dmd.110.035436.","journal-title":"Drug Metab Dispos"},{"key":"1598_CR48","first-page":"4075","volume":"57","author":"GT Chang","year":"1997","unstructured":"Chang GT, Blok LJ, Steenbeek M, et al. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res. 1997;57:4075\u201381.","journal-title":"Cancer Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01598-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:33:53Z","timestamp":1762148033000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01598-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01598-2","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The authors reported that the funding section was incorrect.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human participants were not involved in the present study. The animal study protocol was approved by the Animal Care and Use Committee of Guangzhou Medical University (Approval No. GY2023-482 and date of approval 2023\/10\/09).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read the manuscript and agreed to submit the paper to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}